Cabio Biotech Dividends

688089 Stock   18.09  0.25  1.40%   
As of January 6, 2025, Dividends Paid is expected to decline to about 35.7 M. Cabio Biotech's past performance could be the main factor of why investors trade Cabio Biotech Wuhan stock today. Investors should clearly understand every aspect of the Cabio Biotech dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Cabio Biotech's dividend schedule and payout information. Cabio Biotech Wuhan dividends can also provide a clue to the current valuation of Cabio Biotech.
Last ReportedProjected for Next Year
Dividends Paid42.1 M35.7 M
One of the primary advantages of investing in dividend-paying companies such as Cabio Biotech is that dividends usually grow steadily over time. As a result, well-established companies that pay dividends typically increase their dividend payouts yearly, which many long-term traders find attractive.
  
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Cabio Biotech must own a stock before its ex-dividend date to receive its next dividend.

Please note, there is a significant difference between Cabio Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabio Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabio Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Compare Dividends Across Peers

Specify up to 10 symbols: